TDRD Flashcards

1
Q

So What makes a drug an Ideal Agent?

A

Hypnosis and amnesia
Rapid onset and rapid metabolism to inactive metabolites
Minimal CV or respiratory depression
No histamine release, non-toxic, nonirritating
No untoward neurologic issues (seizures, myoclonus or neurotoxicity)
Good analgesic, antiemetic and cardio protective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

5 rights

A

Right drug, patient, dose, route, time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Propofol (Diprivan)

A

Stimulation of GABA, highly lipid soluble
Uses: TIVA, induction, antiemetic qualities, outpatient surgery, endoscopy, MAC
Contraindicated in allergies to eggs, egg products, soybeans or soy products (?)
Pain on injection (Lidocaine: to mix or not to mix)
Can support bacteria
Good up to 12 hours in opened vial
Good for 6 hours after being drawn into a syringe
CV: decrease HR and BP, decreased SVR
Dose dependent respiratory depression
Minimal residual CNS effects
Decrease in CBF and ICP
Protein binding: 97% to 99%
Dosing:
1-2.5 mg/kg IV induction (2 mg); 25-200 mcq/kg/min sedation/maintenance
Pharmacodynamics
Onset: 30 sec
Duration: dose and rate dependent
Elderly:
More sensitive, prolonged effects possibly due to decreased CO and clearance
Children:
Large volume of distribution and quicker clearance (may need larger dose)
Obese:
Base dosing on lean body weight
Chronic Alcoholism? CV Disease?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lidocaine

A

Dose: 0.5-1.5 mg/kg (adjusted dependent on the patient)
Older adults: 0.5-1 mg/kg

  • Hemodynamically unstable: keep less then .5mg/kg
  • Keep it on the lower side if they are less than 60 kg (?)

Administered to:

  • Suppress the coughing reflex during laryngoscopy and intubation
  • Reduce airway responsiveness to noxious stimuli
  • Reduces pain caused by IV injection agents

It might increase the hypotensive effects of sedative-hypnotic agents

Careful in cardiac patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ketamine (Ketalar)

A

Noncompetitive NMDA receptor antagonist that blocks glutamate
Stimulates SNS: inhibits the re-uptake of Norepinephrine, dissociative anesthetic
Indications: induction, sedation, CV collapse, sedation for mentally challenged, “bad” epidural/spinal
Effects:
Intense analgesia (review the opioid receptors)
CV: increase in BP, HR, CO, PAP, CVP, CI
Respiratory: minimal depression, maintains upper airway reflexes, increased oral secretions (Glyco), bronchodilator
Emergence delirium: low lights, quiet room, VERSED

Increases in ICP?
Phencyclidine derivative, hallucinogenic, use VERSED
Norketamine is an active metabolite, 1/3 to 1/5th as potent as Ketamine
Dosing
Induction: 1-2 mg/kg IV, 4-5 mg/kg IM, titrated for effect
In Low doses it can be opioid sparing
Pharmacodynamics
Onset: IV in 30 sec; IM in 2-4 min
Duration: 10-15 min (IV), 15-25 min (IM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Can use Ketamine in Bronchospastic Patients

A

**Know it*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Thiopental (Pentathol)

A

Introduced in 1934
No longer available in the United States or elsewhere
Short acting barbiturate, activates GABA
Uses: Sedative, hypnotic, anticonvulsant, treatment of ICP (neuro cases), induction of anesthesia
Effects:
Hypotension
Decrease in CBP and ICP
May increase N/V
Some histamine release
500mg vial

Contraindicated in:
Acute Intermittent Porphyria or Variegate Porphyria
Status Asthmaticus
Protein Binding: 72%-86%
Avoid extravasation  necrosis
Dosing:
Induction: 3-5 mg/kg IV in adults
Pharmacodynamics
Onset: 30-60 sec
Duration: 5-30 min
Hepatic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Etomidate (Amidate)

A

Ultrashort-acting nonbarbiturate hypnotic, depresses RAS
Uses: induction, procedural sedation
Effects:
Minimal CV effects, decrease in CMR, CBF, ICP
Respiratory depression
Potential for increased N/V and pain on injection (per Dr. Havenstein and Crosse??????). WHY can it burn? glycerol
Myoclonic movements can be decreased with opioids
Temporary Adrenocortical suppression limits long-term use

Protein Binding: 76%
Dosing:
Induction: 0.2-0.3 mg/kg
Pharmacodynamics
Onset: 30-60 seconds
Hepatic enzyme and plasma esterase hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dexmedetomidine (Precedex)

A

Highly selective, potent central acting Alpha2 adrenergic agonist, results in inhibition of norepinephrine release
Uses: procedural sedation, analgesia, awake fiberoptic intubation, postop sedation, pediatrics
Effects:
Bradycardia, sinus arrest and hypotension (tx with atropine, ephedrine and volume)
Dose dependent analgesia, anxiolysis and sedation with minimal respiratory depression
Protein Binding: 94%
Dosing RANGES:
Procedural sedation: 0.5 -1 mcg/kg over 10 min: infusion .3-.7 mcg/kg/hour
Awake Fiberoptic intubation: 1 mcg/kg over 10 min: infusion 0.7 mcg/kg/hour until intubated
Pharmacodynamics
Onset: 5-10 min; peaks in 15-30 min
Duration: 60-120 min (dose dependent)
Hepatic metabolism
Urinary excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Methohexital (Brevital)

A

Rapid Ultrashort-acting barbiturate, enhances effects of GABA
Uses: ECT(gold standard), ENDO, very short procedures
Effects: deep sedation, skeletal muscle hyperactivity, pain on injection
Must be reconstituted into a 1% (10mg/cc) solution for intermittent IV use

Shortest acting barbiturate and does NOT have anticonvulsant activity (lowers the seizure threshold)
Great for Electroconvulsive Therapy
Pharmacodynamics
Dose: 1-1.5 mg/kg
Onset: < 1 min
Duration: 5-7 minutes
Hepatic metabolism
Urinary Excretion
RAPID redistribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are 3 ways to cause muscle relaxation?

A

Regional, neuromuscular blocker, inhalational anesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neuromuscular blockers listed

A

Depolarizing – succinylcholine (Anectine, SCH)

Nondepolarizing:
Rocuronium (Zemuron)
Vecuronium (Norcuron)
Pancuronium (Pavulon)
Benzylisoquinolines:
Mivacurium (Mivacron)
Atracurium (tracrium)
Cisatracurium (Nimbex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Depolarizing Relaxant

A

Succinylcholine (suxamethonium, Quelicin, SCH or Anectine) (200mg - 20mg/ml)
Binds to 2 alpha subunits of nicotinic cholinergic receptors, allows sodium and calcium influx, potassium efflux, resulting depolarization of muscle
Remains depolarized until SCH diffuses away from receptor
Mimics action of Acetylcholine (AcH)
Uses: rapid muscle relaxation, routine intubation, very short cases, OB, RSI, Laryngospasm
What you should know about SUX!
Can cause Hyperkalemia
Triggering Agent for Malignant Hyperthermia
Minimal Histamine release
Decrease HR due to muscarinic stimulation
SCH apnea/Psuedocholinesterase Abnormality
Phase I normally
Phase II block from large or repeated doses
Fasciculation’s can cause muscle pain Postop
In children, increased risk of increased K and cardiac arrest from undiagnosed myopathies

Metabolism:
Butyrylcholinesterase (synthesized by the liver and found in the plasma) also called plasma cholinesterase
SCH diffuses away from the NMJ, hydrolyzed in the plasma by plasma cholinesterase
Decreased levels of pseudocholinesterase can prolong the block (pregnancy, liver disease)
Succinylmonochline is a weak active metabolite
Dosing:
1-1.5 mg/kg IV for rapid sequence, 2 mg/kg IV in smaller children, 3-5 mg/kg IM, 20 mg IV for laryngospasm
Onset: 30-60 sec IV, 2-5 min IM
Duration: < 10 min IV, 10-30 min IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug errors? most common pic

A

Misc biggest category …Succinylcholine 17.1% , inhalational 13.2, opioids, local,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Malignant Hyperthermia

A

Succinylcholine, inhalational anesthetics - releases Ca++ - sarcoplasmic reticulum, Mutations in the RYR1 gene (ryanodine receptor)- increased ETCO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nondepolarizing Relaxants intro

A

Compete with/block Ach at the nicotinic receptor alpha subunits on motor endplate inhibiting depolarization
Uses: Muscle Relaxation for surgery, intubation
Aminosteroids
Primarily liver breakdown, kidney excretion, minimal histamine release, highly ionized at physiologic pH, small volume of distribution, limited lipid solubility
Potential for allergic reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Nondepolarizing Relaxants

Rocuronium (Zemuron)

A

Rocuronium (Zemuron) (50mg/100mg vials, 10mg/ml)
Intermediate action, rare histamine release, no effect of BP or HR, can be used to defasciculate with SUX
Dose:
0.6/1.2 mg/kg (higher dose for RSI and lower dose for routine intubation/surgical relaxation)
5 mg for defasciculating dose with SUX
Maintenance/Repeat dose of 0.1-0.2 mg/kg as needed
Pharmacodynamics
Onset: 1-2 min depending on dose
Duration: about 30 min
Eliminated primarily by the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nondepolarizing Relaxants- Vecuronium

A

Vecuronium (Norcuron) (10mg 1mg/ml)
Intermediate NMB, no histamine release, cardiac stable, might precipitate with Thiopental
Dose:
Induction/intubation: 0.08-0.1 mg/kg
Pretreatment/priming with 10% of intubation dose Maintenance for surgical relaxation: 0.01 mg/kg
Pharmacodynamics
Onset: 2-3 min (good intubating conditions); 3-5 min (maximal blockade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nondepolarizing Relaxant- Pancuronium

A

Pancuronium (Pavulon) (10mg - 1mg/ml)
Long acting, no histamine release, modest tachycardia due to antimuscarinic stimulation, norepinephrine release and reduced uptake of norepinephrine by adrenergic nerves
Increase in BP, careful in any patient that will not tolerate increase HR and cardiac output
Dose:
Initial: .08-.12 mg/kg
Maintenance: 0.01 mg/kg
Pharmacodynamics
Onset: 2-3 min
Duration: 60-100 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Benzylisoquinolines Intro

A

Hofmann Elimination
Ester hydrolysis
Plasma cholinesterase metabolism
Histamine release
Some changes to BP and HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hofmann Elimination

A

Spontaneous, non-enzymatic, non-organ dependent chemical breakdown at physiologic temperature and pH
Temperature increase and pH increases……. Increased metabolism
Temperature decreases and pH decreases……. Decreased metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benzylisoquinolines- Mivacurium (Mivacron)

A

10mg/20mg vial 2mg/ml -

HISTAMINE RELEASE when given quickly
Spontaneous recovery from the block is rapid
Metabolism:
Hydrolysis by plasma cholinesterase
Dose: .15-.2 mg/kg (intubation) 4-10 mcg/kg/min infusion
Pharmacodynamics:
Onset: 1 min
Duration: 10-20 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Benzylisoquinolines- Atracurium (Tracrium)

A

50mg 10mg/ml

Intermediate acting, Hofmann Elimination and nonspecific ester hydrolysis, small histamine release, minimal change in BP
Primary metabolite is Laudanosine, which can produce rare seizure activity (tertiary amine)
Dose: 0.3-0.6 mg/kg
Pharmacodynamics
Onset: 2-3 minutes
Duration: 20-35 min, 95% recovery in 60-70 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Benzylisoquinolines - Cisatrcurium (Nimbex)

A

20mg 2mg/ml

Intermediate/long acting, predominantly Hofmann elimination, NO histamine release, NO changes in BP/HR
Dose: 0.1-.15 mg/kg IV
Onset: 2-3 min, peaks in 3-5 min
Duration: 40-70 min; 20-35 min to begin recovery: up to 93 min for 90% return

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Reactions- drugs that cause anaphylaxis reactions
Under anesthesia what would you see tachycardia, hypotension, bronchospasm – wheezy peak pressure – different than an awake pt. sugammadex (high doses) , rocuronium, antibiotics
26
Factors Affecting Reversal
Intensity of the block Dose and choice of NMB Drug interactions Choice of reversal agent Disease process (liver failure)
27
ways to reverse a patient?
Time, drugs, Hoffman
28
Acetylcholinesterase Inhibitors
Acetylcholinesterase : enzyme responsible for rapid hydrolysis of released acetylcholine Reversal of NMB, myasthenia gravis (Diagnosis and treatment), treatment of central anticholinergic syndrome Inhibiting the action of acetylcholinesterase, Increase Ach Unwanted muscarinic stimulation SLUD- salivation, lacrimation, urination, and defecation, which are the clinical signs associated with muscarinic cholinergic overstimulation(I ADDED) Increased bronchial secretions/bronchospasm Bradycardia caused by slowing conduction velocity of the cardiac impulse through the AV node CNS excitement (physostigmine)
29
Reversal Agents - Acetylcholinesterase Inhibitors/Selective Relaxant Binding Agent
Acetylcholinesterase Inhibitors Neostigmine Edrophonium Pyridostigmine Selective Relaxant Binding Agent Sugammadex
30
Acetylcholinesterase inhibitors - Neostigmine (Prostigmin)
10mg 1mg/ml ## Footnote Inhibits hydrolysis of ACh by AChAsE Blocks AChAse at all cholinergic synapses causing parasympathetic effects Used with glycopyrrolate (anticholinergic) to decrease muscarinic side effects of Neostigmine Quaternary ammonium compound therefore does not penetrate the blood-brain barrier (BBB) very well Ceiling effect- 5mg When to Reverse with Neostigmine.. Used in deep blocks Shouldn’t be given until spontaneous recovery evident (TOF) More effective with moderate blocks but slow acting Ceiling effect Because of this ceiling effect Neostigmine can’t effectively antagonize deep blocks Giving more may even worsen it and potentially increase the incidence of residual block 15 mins when at right time? I ad ded Given with Glycopyrrolate- .2mg/ml 5ml vial =1 mg
31
Acetylcholinesterase inhibitor Edrophoniun (Enlon)
Used with atropine due to rapid onset Inhibits the destruction of ACh by AChE Enlon-Plus is a mixture of Edrophonium and atropine together in the same vial Rapid onset (1-2 min), short duration Quaternary amine Dose: .5-1 mg/kg mixed with atropine 0.014 mg per 1 mg of edrophonium Enlon-plus: .05-.1 mg/kg slowly over 1 minute Enlon plus!! Is a mixture with atropine\*\*\* Atropine is .4mg/ml 20ml vial? per pic
32
Cholinergic Syndrome (Crisis)
Excessive stimulation of Ach receptors: either direct stimulation of receptor or inhibition of acetylcholinesterase Overstimulation of nicotinic and muscarinic receptors How: Too much Anticholinesterase, organophosphate poisoning/nerve gas, certain drugs Symptoms: Muscarinic (SLUD), muscle cramping, weakness, decrease BP/HR, CNS (restless, anxiety, confused, seizures, coma) Treatment: Atropine, benzos (versed/valium),Oximes (pralidoxime, obidoxime)
33
Acetylcholinesterase inhibitor - Physostigmine (Antilirium)
Tertiary amine: only anticholinesterase (acetylcholinesterase inhibitor, cholinesterase inhibitor) that crosses the blood brain barrier Not used for reversal of muscle relaxants Used to treat anticholinergic toxicity S/S: flushing, dry skin and mucous membranes, mydriasis with loss of accommodation, altered mental status, fever and urinary retention CNS: restless, shivers, agitation, disoriented Types of anticholinergics (atropine, scopolamine, antihistamines, antipsychotics, cyclic antidepressants)
34
Selective relaxant binding agent - Bridion (Sugammadex)
Used for reversal of Zemuron/Vecuronium Selective relaxant binding agent that encapsulates rocuronium or vecuronium preventing its action: can reverse profound neuromuscular blockade What’s the dose of Sugammadex? Dosing for Rocuronium and Vecuronium 2 mg/kg TOF of 2 4 mg/kg 1-2 post-tetanic counts (PTC) and no TOF twitches Dosing for Rocuronium only 16 mg/kg to reverse RSI dose of Rocuronium of 1.2 mg/kg after 3 minutes What are the Warnings and Precautions on Sugammadex? Anaphylaxis and Hypersensitivity Bradycardia Risk of coagulopathy and bleeding Increases in PTT and PT, especially in those who were treated with heparin or low molecular weight heparin for thromboprophylaxis Interactions with other drugs (hormonal contraceptives and Toremifene)……… suggest NO sex for 7 days Common adverse reactions: N/V, hypotension, headache
35
**Anticholinergic Agents/Muscarinic Antagonists** * **Muscarinic Antagonists**
Competitive inhibitors of Ach at parasympathetic muscarinic receptors to increase the heart rate Inhibits salivary, bronchial, and GI secretions Reduces gastric motility Causes bronchodilation Antagonize the muscarinic effects of anticholinesterases used to reverse NDMR
36
Atropine
Competitive acetylcholine antagonist at central and peripheral receptors, antimuscarinic, naturally occurring alkaloid Tertiary amine Indications: reversal, brady arrhythmias/vagal stimulation, oculocardia reflex, peritoneal stimulation Careful use in narrow-angle glaucoma Crosses placenta to increase FHR and decrease beat to beat variability in baby Dose: 0.014mg / mg of edrophonium or .2-.4mg for vagal stimulation Onset: \<1 min; duration: up to 30 min Dilating an eye with narrow angle glaucoma closes the angle completely. Medications can worsen both types of glaucoma.
37
Glycopyrrolate (Robinul)
1mg .2mg/ml Synthetic antimuscarinic, competitive Ach antagonist Uses: in combo with Neostigmine for reversal, antisialogogue(xerostomia), increase HR Quaternary ammonium Dose: 0.2 mg per 1 mg Neostigmine Onset: about 1 min IV; 15-30 min IM Duration: 2-4 hours No CNS or mydriasis
38
Scopolamine
.4mg/ml Competitive antagonist of Ach at muscarinic receptors, antagonizes histamine and serotonin Tertiary amine, naturally occurring alkaloid Uses: Decreases secretions, PONV, motion sickness/vertigo, dilate pupils and cycloplegia, unstable trauma pt, sedation/amnesia Toxic psychosis in elderly Effects from restlessness to agitation IM/IV before surgery; transdermal patch (what should we warn them about) Typical dose: 0.3-.5 mg IM or IV Cycloplegia: paralyzing the ciliary muscle and thus the power of accommodation. Crosses BBB – more geared toward motion sickness- different drug with different modes of action for PONV – careful with older pts dilate eyes… Also dry mouth\*\*\*
39
Central Anticholinergic Syndrome
Overdose of scopolamine and sometimes Atropine(tertiary amines), phenothiazine Signs: anxiety, disoriented, hyperactive, sedation, seizure, mydriasis, increased HR, Atropine flush, dry/flushed skin, atropine fever Can be mistaken for delayed recovery from anesthesia Treat with Physostigmine: tertiary amine that crosses the BBB Dose: 1-2 mg IV and may need to be repeated every 1-2 hours (physostigmine is metabolized rapidly) Muscarinic Antagonist Toxicity Anticholineric toxidrome - pic
40
* *Vasopressors/** * *Sympathomimetics- Vasopressors are not a replacement for:**
Adequate volume Blood TOO MUCH ANESTHESIA
41
Ephedrine
Mixed acting synthetic noncatecholamine sympathomimetic Indirect Effect Ephedrine into Alpha-1 and Beta-1 receptors displaces norepinephrine presynaptic Norepi is released and activates the postsynaptic receptors to cause arterial and venous vasoconstriction and increased myocardial contraction Direct Effect Directly stimulates Beta-2 Increased heart rate, cardiac output and some SVR increase Uses: increase BP/HR, CO and contractility, PONV, bronchodilator effect Used in Obstetrics: can cause fetal tachycardia and acidosis which was associated with lower umbilical artery pH at delivery Contraindicated with MAO inhibitors, Pheochromocytoma Careful use in CAD Tachyphylaxis (depletion of presynaptic norepi) Dose: 5-10 mg at a time to increase BP/HR; Ephedrine 25mg/Vistaril 25 mg IM for antiemetic effect 20 min before end of surgery 50mg 5mg/ml - make by taking 1ml with 9ml of normal saline = 1cc (50 mg) + 9 cc of NS = 5 mg/cc
42
Phenylephrine (Neosynephrine)
Directly stimulates alpha-1 receptors, minimal effect on alpha-2 or Beta receptors Uses: hypotension, decrease CO in patients with LV dysfunction Causes constriction of cutaneous, mesenteric, splenic and renal Vasopressor of choice in OB Causes vasoconstriction to increase BP, reflex decrease in HR, increase in coronary blood flow Dose: 50-100 mcg titration to effect 100 mcg/ml 1g in 10ml how to mix = .1 cc (10mg/cc vial) + 9.9 cc NS = 100 mcg/cc
43
EPHEDRINE vs. NEO in OB
Ephedrine won’t decrease uterine blood flow Some antiemetic property, good for hypotension from regional anesthesia Can cause fetal tachycardia and acidosis Neosynephrine is preferred in OB now Good for hypotension post-regional Faster onset and shorter duration of action Maintains fetal pH
44
WHY IS THE PATIENT HYPERTENSIVE?
Identify the potentially reversible causes of hypertension! Pain Hypothermia Anxiety Increased ICP Bladder distention Poorly controlled HTN Lack of anesthesia
45
Labetalol (Trandate)
Nonselective Beta-1 and Beta-2 with selective Alpha-1 adrenergic antagonist, primarily considered a Beta Blocker Uses: acute and chronic HTN in pregnant pts, treat increases in BP and HR from stimulation (intubation) BP reduction causes decreased CO and PVR, can depress cardiac contractility, minimally affects CBP or ICP Contraindicated in bronchospastic disease, impaired cardiac conduction or underlying resting bradycardia Dose: 5-20 mg boluses IV; onset: 1-2 min; duration: up to 6 hours 100mg/20ml 5mg/ml
46
Esmolol (Brevibloc)
Rapid-onset and short-acting selective Beta-1 antagonist Uses: treat perioperative tachycardia, pre-treatment during intubation/extubation Decrease in HR, myocardial contractility, CO and some decrease in BP, no rebound effects Contraindicated in bradycardia, heart block, cardiogenic shock and heart failure Dose: 10mg boluses IV, infusions of 50 mcq/kg/min after a .5mg/kg bolus; Onset: rapid; duration: 10-15min Metabolized by plasma esterases 100mg 10mg/ml - fast on fast off
47
Propranolol (Inderal)
Nonselective Beta-1 and Beta-2 antagonist Uses: HTN, angina, acute MI, pheochromocytoma, treat anxiety and panic attacks Decreases BP due to decrease in myocardial contractility, HR, CO therefore decrease in myocardial oxygen demand Careful use in bronchospastic disease, AV block and bradycardia Dose: 1 mg-3mg IV (no more than 1 mg/min), titrated to effect; onset: around 2-3 min; duration up to 4-6 hours (depending on the source you read) may give Esmolol not working 1mg/ml
48
Metoprolol (Lopressor)
Selective B1 adrenergic receptor antagonist, prevents inotropic and chronotropic responses to Beta stimulation Uses: rapid HR and contractility control, CO and therefore decrease BP, treatment for MI Dose: 1-5 mg IV up to 15 mg Half-life of 3-4 hours 5mg 1mg/ml
49
Vasopressin
Antidiuretic hormone, released by the posterior pituitary V1 (CV effects), V2 (renal), V3 (pituitary) receptors Uses: cardiac arrest, sepsis, shock and h**ypotension secondary to ACE inhibitors refractory to catecholamines or sympathomimetics** Dose: I0/20 units/ml in 10/20 ml syringe, 1-2 unit bolus (mix with Saline) Potent vasoconstrictor: arterial and mesenteric I think used in vasoplegia 1unit per ml?
50
Hydralazine (Apresoline)
Direct systemic arterial vasodilator causing relaxation of arterial smooth muscle; blocks calcium release from sarcoplasmic reticulum; decreases BP with increase in HR, SV, and cardiac output Uses: HTN, heart failure, Eclampsia Potential for increased ICP, careful/contraindicated in CAD Dose: 2.5-5 mg IV titrated every 20-30 min; onset: 15-30 min; duration: 4-6 hours 20mg/ml pregnant start labetalol then hydralazine then nitroprusside
51
What is PONV
Postoperative nausea and vomiting (PONV) defined as nausea and/or vomiting within 24 hours of surgery Along with pain, PONV is the highest complaint and leading cause of unanticipated hospital admission after outpatient surgery 40% of patients without prophylaxis have nausea who have general anesthesia 80% of high risk patients without prophylaxis
52
Risk Factors for PONV
Patient factors: female(strongest indicator), nonsmoker, hx of PONV and/or motion sickness Surgical factors: longer procedures, certain procedures (GYN, laparoscopy, ENT, Breast/Plastics) Anesthetic factors: inhalationals, nitrous?, neostigmine, opioids Kids: weak association with age, greatest association is the surgical procedure (hernia, tonsils/adenoids/ strabismus surgery, male genitalia) Adults: risk may decrease with age
53
PONV MULTIMODAL
PONV is associated with: dehydration, electrolyte abnormalities, wound dehiscence, bleeding, airway compromise and UNPLANNED ADMISSIONS and PATIENT DISCOMFORT
54
Scopolamine
Prevention of Motion Induced nausea and PONV Trauma patients Motion sickness is caused by stimulation of the Vestibular apparatus Opioids and morphine increase vestibular sensitivity to motion! Transdermal absorption of scopolamine (sustained plasma concentration) so may have less sedation, cycloplegia and drying of secretions Visual disturbances due to anisocoria (unequal pupil size)
55
Zofran (Ondansetron)
Selective 5-HT3 receptor antagonist in GI tract and Chemoreceptor Trigger Zone Preventative and rescue treatment for N/V, used in chemo Side Effects: headaches, diarrhea Careful use in patients with prolonged QT interval: can lead to torsades Questionable use in Obstetrics Dose: 4 mg IV; duration: 4-6 hours; extensive hepatic metabolism WHEN DO YOU GIVE IT? literature 10 mins before end 4 hrs maybe 2x? 4mg 2mg/ml
56
Decadron (Dexamethasone)
Nausea and Vomiting prevention, ENT, traumatic intubations….. Corticosteroid, used in combination with other antiemetics, lowers surgical inflammation, low cost Mechanism is unclear, proposed to centrally inhibit prostaglandin synthesis and control endorphin release Side effects: genital itching/burning (give after patient asleep), hyperglycemia Careful in diabetics, wound healing issues? Dose: 4-12 mg IV on induction; duration about 24 hours 20mg 4mg/ml
57
Phenergan (Promethazine)
Phenothiazine, H1 receptor antagonist (antihistamine), Anticholinergic action (motion sickness), **D2 antagonist in CTZ** Considered a First-generation H1 receptor antagonist due to sedation potential Uses: N/V and anxiety Causes sedation, potentiates sedative effects of benzos and opioids (Cesarean delivery), hypotension, extrapyramidal symptoms (Akathisia) Dose: 12.5-25 mg IV (diluted and given slowly in good IV); onset: 3-5 min; duration: 4-6 hours 50/25mg /ml? dont give to parkinson patient?
58
Aspiration Prophylaxis
Factors associated with pulmonary complications of aspiration: Volume of gastric contents Acidity of the aspirated gastric contents
59
REGLAN (METOCLOPRAMIDE)
Gastrointestinal **prokinetic**, increases LES tone, enhances response to AcH in upper GI tract to **enhance gastric motility and accelerate gastric emptying/reducing gastric volume** Antiemetic action probably due antagonism dopamine-agonist effects in the chemoreceptor trigger zone Inhibition of dopamine receptors within the CNS….. Crosses the BBB Can cause sedation, restlessness, extrapyramidal symptoms (tardive dyskinesia) Contraindicated bowel obstructions and Parkinson's, restless leg syndrome, or movement disorders related to dopamine inhibition or depletion What pt would you not give this to- small bowel obstruction… Parkinson, old people\*\*= they can have increase Parkinson make crazy kinda like scpalmine Treatment of diabetic gastroparesis, GERD, OB Usually given in preop for aspiration prophylaxis Does not alter gastric fluid pH Dose: 5-10 mg IV in preop; duration: 1-2 hours; onset: 1-3 minutes, can be used as a rescue drug in PACU Potential for Neuroleptic Malignant Syndrome What is NMS? How is it treated? What other syndrome is it similar to? 10mg 5mg/ml RSI, Trauma, pego, bad reflux – aspiration prophylaxis only moves things but does not help with gastric ph
60
Pepcid (Famotidine)
H2- receptor antagonist, inhibits gastric acid secretion/fluid volume and raises gastric pH Given in preop to decrease risk of pulmonary aspiration in at risk patients Dose: 20 mg IV Onset: 30 min – 1 hour 20mg 10mg/ml
61
Vistaril (Hydroxyzine)
Blocks Ach in the vestibular apparatus, blocks H1 receptors in the solitary tract, antihistamine Uses: N/V, pruritus (pregnancy), antianxiety Side effects: sedation, pain on injection Dose: 25 mg mixed with Ephedrine 25 mg IM 20 minutes before the end of surgery (careful in HTN patients/outpatients) 100mg 50mg/ml
62
OB- Pitocin (Oxytocin)
Uses: induction of labor and control postpartum uterine bleeding, after Suction D&C Indirectly increases intracellular calcium, directly stimulates the oxytocin receptor on the myometrium, some antidiuretic Contraindicated in: fetal distress, unfavorable fetal positions, previous uterine rupture Effects: flushing, brady/tachycardia, hyper/Hypotension Dose: 10-40 U in 1000cc LR; onset: immediate; duration: within 1 hour PRESSOR EFFECTS? We never give IV\*
63
OB- Methergine (Methlyergonovine)
Semisynthetic ergot alkaloid, increases motor activity of uterus by acting directly on smooth muscle to increase tone, rate and amplitude of contraction Arterial vasoconstriction by alpha stimulation, inhibition of endothelial derived relaxation factor release Contraindications: severe HTN, PIH and cardiac disease Dose: 0.2 mg IM every 2-4 hours (max 5 doses); onset: 2-5 min; duration: about 3 hours NEVER IV can raise BP alpha. .2mg/ml
64
OB- Hemabate (Carboprost)
Synthetic analogue of prostaglandin F2 that stimulates uterine contraction, increase of myometrial calcium, stimulates smooth muscle of GI tract to cause diarrhea Increase in temperature possibly due to effect on hypothalamic thermoregulation(can increase 2 degrees) Airway constriction and wheezing, increase CO, BP and PVR (constriction of vascular smooth muscle) Dose: 250 mcq IM repeated every 15-45 min, max 8 doses; onset: immediate; duration: 2 hours 250mcg/ml
65
OB- Misoprostol (Cytotec)
Synthetic prostaglandin E1 Indicated for uterine atony, abortions, cervical ripening, peptic ulcer disease Dose: 1-2 tablets buccal (200 mcq each), can be given rectally and vaginally (By OB); onset: rapid; half life is 20-40 min
66
Magnesium Sulfate (MgSO4)
Used to prevent eclamptic seizures (decrease incidence of seizure by 50 %), stop premature labor (tocolytic) Inhibition of acetylcholine release at NMJ Mild vasodilator that decreases uterine activity to increase uterine blood, dilates liver beds and kidneys to increase function, decrease SVR Potentiates nondepolarizers and depolarizers (probably not enough to alter dose) Can cause pulmonary edema, may be some correlation with chorioamnionitis Dose: 4 grams over 20 min, 2-3 grams/ hour infusion; onset: immediate; duration: 20-30 min with good renal perfusion Monitor magnesium levels, treat magnesium toxicity with calcium gluconate 1 gram over 2 min, fluids, diuresis, O2 Crosses the placenta therefore neonate may show signs of respiratory depression, apnea and decreased tone Mg plasma levels- pic
67
Blood Pressure Control In Parturients
Labetalol: combined alpha and beta antagonist, rapid onset, few neonatal complications (bradycardia) Hydralazine: potent vasodilator, decrease afterload, decrease peripheral resistance (especially when used with volume repletion), decrease maternal BP and uterine vascular resistance to increase Uterine blood flow Limiting side effects are maternal tachycardia (reflex sympathetic response to direct vasodilation), vomiting, tremors **Nipride:** for acute hypertensive crisis, potent arteriolar dilator, rapid onset and short duration, maternal/fetal cyanide toxicity is a concern, but at low doses 5-10 mcg/kg/min is unlikely **Nitro:** venodilator to decrease cardiac filling pressures by acting on capacitance vessels, may get reflex tachycardia Volume Repletion for severe pre-eclampsia, intravascular repletion can improve the low CO, when right and left cardiac filling pressures normalize, CI improves, maternal HR and SVR decrease, fetal circulation improves
68
Gabapentin (Neurontin)
Gabapentinoid Decrease hyperexcitability of dorsal horn neurons caused by tissue damage Modulation of calcium-induced release of glutamate centrally in dorsal horn Activation of descending noradrenergic pathways in the spinal cord and brain 300-600 mg PO preop Careful in old age and low GFR, morbidly obese, OSA Used a lot in chronic pain/neuropathic pain Can increase postoperative sedation
69
Celebrex
Selective COX-2 inhibitor PO dose of 100-200 mg Associated with increased risk of stroke and MI, worsening of HTN Careful/Avoid in known history of CAD or cerebrovascular disease -I added - COX-1 generates prostaglandins that are involved in the protection of gastrointestinal mucosa, while COX-2 generates prostaglandins that mediate inflammation and pain in sites throughout the body.
70
Methocarbamol (Robaxin)
Central Acting Skeletal Muscle Relaxant Depresses the CNS leading to relaxation of the muscles Used as an adjunct with other medications Can cause sedation Dose: 1 gram IV slowly over 15-20 minutes Can cause hypotension, bradycardia, and convulsions if given rapidly Should probably be avoided in liver and renal dysfunction also get chills?
71
Toradol (Ketorolac)
NSAID, inhibits cyclooxygenase, preventing thromboxane synthesis, which is necessary for platelet aggregation, inhibits prostaglandin synthesis Non-Selective Cox 1 and Cox 2 inhibitor Uses: decrease pain and cramping, postoperative cesarean delivery, orthopedics, laparoscopy…. Minimal CNS effects, no respiratory depression or sedation Careful in elderly and renal Careful use in elderly, bleeding issues, renal impairment with poor creatinine clearance, ASA allergy, asthma, nasal polyps Decreases narcotic us postop 30 mg Toradol IV = about 10 mg morphine Dose: 15 – 30 mg IV every 6 hours; Onset: 10-30 min; Duration: 4-6 hours; peaks in 1-2 hours Take Home: We use Toradol frequently. Make sure your patient has no relative or absolute contraindication to its use. Always ask the surgeon before administering
72
Samter’s Triad
-added syndrome of airway inflammation characterized by rhinosinusitis with polyposis, asthma, and nonsteroidal anti-inflammatory drug (NSAID) intolerance. Samter's Triad is usually treated by managing asthma symptoms, taking corticosteroids, and having nasal surgery to remove polyps ## Footnote Also called Aspirin Exacerbated Respiratory Disease (AERD) Chronic condition that includes all three triad features and sensitivity to NSAIDS and ASA Acute reactions to aspirin and NSAIDs can be severe and life threatening Usually diagnosed in adulthood (7-10% of adult) May have respiratory reactions to alcohol and impaired sense of smell
73
Ofirmev (IV Acetaminophen)
Non-opioid alternative or in combination with other drugs Careful use in hepatic impairment/Acute disease, chronic alcoholism, chronic malnutrition, severe hypovolemia, or severe renal impairment Dose: \>50 Kg dose is 1000 mg IV over 15 min, repeated every 6 hours or 650 mg every 4 hours (Max 4 grams in 24 hour period); \< 50 Kg adult is 15mg/kg every 6 hours not to exceed 3g/day PO in preop
74
Caldelor 800mg/8ml
**CALDOLOR must be diluted prior to use. Infusion of the drug product without dilution can cause hemolysis. CALDOLOR should not be given as an IV bolus or IM injection.** **ADVERSE REACTIONS**:The most common adverse reactions are nausea, flatulence, vomiting, headache, hemorrhage and dizziness (\>5%). The most common adverse reactions in pediatric patients are infusion site pain, vomiting, nausea, anemia and headache (≥2%). Max dose: 3200 mg/day (800 mg/6 hours) or 2400 mg (40mg/kg) in Pediatrics less than 17 years old **CONTRAINDICATIONS**CALDOLOR is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to ibuprofen or any components of the drug product, and in patients who have a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. **WARNINGS AND PRECAUTIONS**CALDOLOR should be used with caution in patients with known cardiovascular (CV) disease or risk factors for CV disease, a history of peptic ulcer disease and/or GI bleeding, liver disease or symptoms of, hypertension, and heart failure. Avoid use in pregnant women starting at 30 weeks gestation.
75
Methylene Blue
Potent Monoamine oxidase inhibitor (MAOI) Interacts with Serotonin reuptake inhibitors (selective and nonselective, SSI/SSRI) and SNRI (serotonin-Norepinephrine)serotonin toxicity Can induce severe, potentially fatal serotonin toxicity (serotonin syndrome) Careful with BLUE ARM syndrome (no cuff) Serotonin Toxicity- pic
76
Fluorescein Dye
Used to Visualize ureters during cystoscopy Intraoperative urologic dye marker Dose: dependent upon practitioners 50-100 mg IV (100 mg/ml) Usually works within 5 minutes Precautions: Bronchial asthma Avoid extravasation
77
Indigo Carmine
Inactive blue dye routinely given IV during urologic and gynecologic procedures to localize the ureteral orifices Dose: 5 ml (8mg/cc) Can see hypertension due to increased PVR with increased HR Can see Increased BP with reflex decrease in HR On rare occasion can see Hypotension, cardiac arrest and cerebral ischemia
78
Other Drugs/Infusions You Should Review
Nitroglycerine Nipride Dobutamine Dopamine Review your opioids (Dilaudid, Fentanyl) Cox-1 and Cox-2 inhibitors (Celebrex) Gabapentin
79
Nonspecific plasma esterase
Remifentanil Esmolol Remimazolam Clevidipine Atracurium (and hofman Etomidate (and hepatic) Cisatracurium- 30% hof and rest nonspecific?
80
AIP ( ACUTE intermittent porphyria
Etomidate and Barbituates, oral contraceptives, and sulfa drugs 5 ps – Porphobilinogen deaminase deficiency; Pain in abdomen; Psychological symptoms; Peripheral neuropathy; Pee abnormality; Precipitated by drugs - Disorder of porphrin enzyme metabolism in liver or bone marrow- they are involved in heme production. If history must avoid barbs and etomidate. Thiopental and methohexital
81
Protein bound
98% propofol 98-94% benzodiazepine- 94%- Dexmedetomidine 75% Etomidate 20% Ketamine- high lipid solubility
82
GABA A
Propofol (receptor agonist) (enhancement of GABA inhibition – maybe central cholinergic transmition NMDA, alpha adrenergic sites) Etomidate (agonist) Benzodiazepines- agonist -central inhibitory neurotransmitter ( increase frequency of opening \* increase chloride conductance- hyperpolarization of membrane incr resistance to stim. ) Barbiturates- gaba a agonist – involves cortical and brainstem GABA inhibitory pathway
83
NMDA (N- methyl – D – aspartate)
Ketamine - antagonist (phencyclidine PCP derivative) (racemic mixture of S and R enantiomers).. also non-NMDA glutamate receptors, Nicotinic receptors, cholinergic recpetors, monoaminergic receptors, Mu, delta, and kappa – opioid receptors, and inhibits neuronal Na+ channels (local anesthetic action) and Ca+ channels (cerebral vasodilation)
84
Alpha 2 adrenergic agonist
Dexmedetomidine- highly selective specific potent a2 adrenergic agonist compared to clonidine 7-8x more selective- dose dependent sedation/analgesia
85
Glycerol
Propofol Etomidate (propylene glycol) – veno-irritation/ phlebitis Versed does not burn its water soluble but… Lorazepam and diazepam do vein irritant\* propylene glycol Pain on injection - Methohexital
86
CNS
Propofol (depressant, neuroprotective **anticonvulsant** (treat status epilepticus), decrease CMRO2, CBF, and ICP… shortens sz duations (ECT), decrease PONV (10-15 mg IV or 10 micogram/kg/min.) antipruritic effect (10mg) Etomidate- potent vasoconstrictor – reduces CBF, ICP, CMRO2 (myoclonic movements- sz like – use versed/opioid to help**; PROconvulsant**; lowers sz threshold Ketamine- POTENT cerebral vasodilator – _increases CBF 60-80%)_ in normocapnia attenulated with hyperventilation maybe not use increased ICP?? dissociative amnestic state- unconscious – eyes open (nystagmus), maintain spon resp. does not react to pain, prevents hyperalgesia and decrease sensitization to acute pain, acute pain and depression treatment Dexmedetomidine – sedative, anxiolytic, analgesic (spinal cord and brain) pt can follow commands Benzodiazepine- **_ANTICONVULSANT_** , skeletal muscle relaxant (centrally), anxiolysis and sedation, amnesia – Decreaces CMRO, CBF, little effect ICP, upper aireway reflex may decrease and central resp drive. Barbiturates – CNS depressant, neuroprotective, **anticonvulsant**, decreases CMRO2, CBF, ICP (EEG burst suppression thiopental)- loss of consciousness, hypnotic effect- inhibit central excitatory pathway- glutamate via NMDA receptors and acetylcholine _Thiopental- anticonvulsant treat status epilepticus – used induction pt with increased ICP and treats ICP resistant to hyperventilation_- Protects the brain- decreases CBF ICP, CRMO2 – releases histamine from mast cells- **Precipitates with succinylcholine, rocuronium and lidocaine** **_Methohexial (brevital)_** – gold standard for ECT- half-life elimination 4 hours, \***_proconvulsant\*_** activity pain on injection
87
CV
Propofol- decrease SVR, Stroke volume, and CO systolic and diastolic, decrease sympathetic activity- vaso and venodilation – more so after larger dose (dependent), Etomidate- hemodynamically stable\*\* (cardio, trauma, hypovolemic) no effect on it… Ketamine – SNS stimulant induction dose increases HR and BP MAP CO SVR(good for unstable) OB, careful- cardiac severe right heart dysfunction (increases PVR) (good for hypovolemic but not critically ill/shock\*\* they might drop bp if depleted catecholamine stores. Dexmedetomidine – hypotension and bradycardia because high alpha 2 adrenerreceptor activity- esp children – titrate.. blunt hemodynamic SNS effects laryngoscopy – stability as adjuvant Benzodiazepine- minimal cardio depression, can decrease SVP and BP Barbituates- decreases mean arterial pressure, venous vascular tone, and CO, CV depression
88
Pulmonary
Propofol - Resp depress, potent bronchodilator (intracellular ca+), apnea common, maintence dose- increase RR decrease TV Ketamine- no significant depression of vent. Protects airway reflex, muscarinic receptors can increase secretions( glyco) Broncodilates good\*\* Dexmedetomidine- minimal respiratory depression- bolus reduces minute ventilation Benzodiazepines- minimal resp depression ( reversible with flumazenil) Barbiturates- dose dependent respiratory depression- does not cause bronchodilation
89
Major side-effects
Propofol- pain with injection and propofol infusion syndrome, phenyl nuclus and di-isopropyl sidechain – allergic reactions, also genergic metabisulfite\* sulfite sensitivity. Egg/soy- egg white, carful- CV disease trauma/hypotension/ bleeding PROPOFOL infustion syndrome (PRIS) high doses 4mg/kg/hr over 48 hours – acute refractory brady – asystole, unexplained meta acidocis, high K+, rhabdomyo, hyperlipid, enlarged liver, renal failure, EKG and arrhythmida, cardiomyopathies, skeletal mypo high k+ - critically ill (or peds)…. Etomidate – adrenocortical suppression – inhibit 11-beta-hydroxylase prevents cholesterol to cortisol, PONV, Ketamine- Emergence delirium, 5-30%, greater than 2mg/kg, prevent- midazolam, pharm test included bleeding? Dexmedetomidine- bradycardia (40%) and hypotension can give atropine, ephedrine or volume, also omitting loading dose. Can causse dry mouth/nausea and HTN.. Benzodiazepine – can have anterograde amnesia (OB)
90
Metabolism
Propofol- liver – inactive and water -soluble metabolytes kidneys excreted- extrahepatic sites of metabolism 30% kidneys and lungs – broken down pts with different comorbid states.. Ketamine- liver – cytochrome P – 450 enzyme- ACTIVE metabolite Noreketamine- (1/3-1/5 as active) Etomidate- PLASMA ESTERASES and liver – excreted kidneys 80% and bile 20% Dexmedetomidine- Rapid hepatic metabolism involving conjugation, n-methylation, hydroxylation- excreted urine and feces- distib 1/2l 6min elim 1/2l 2 hrs… weak inhibitory properties on CYP-450 can increase plasma concentration of opioids Benzodiazepine Versed- rapid redistribution, hepatic metabolism and renal clearance (careful renal liver dysfuction, age, comorbidies) – 1- hydroxymidazolam metabolite high hepatic clearance Diazepam- intermediate duration- metabolites- oxazepam and desmethylidaepam – slow Lorazepam (long acting inactive metabolietes Barbiturates- primary metabolism is hepatic with inactive metabolites excreted in urine and bile
91
Propofol (2,6 -diisopropylphenol)
1-2.5 mg/kg 30 sec – unconscious Iv MAC- 25-75 mcg/kg/min TIVA GA – 100-200 mcg/kg/min Concentration 10mg/ml (200mg/20ml) Context sensitive half-life – 8 hours - 40 mins
92
Etomidate (carboxylated imidazole derivative)
Initial distribution half-life: 2.7 minutes Redistribution of half-life: 29 minutes Elimination half-life: 3-6 hours Volume of distribution: 2.5-4.5 L/kg Induction dose: 0.2-0.3 mg/kg Usual concentration: 2mg/cc (20mg/10ml)
93
Ketamine
Onset of IV meds: 30-60 seconds Duration: 10-20 minutes Induction dose: 0.5-2 mg/kg IV 4-5 mg/kg IM ◦ Usual concentrations: 10mg/cc (200mg/20ml)
94
Dexmedetomidine
Dose .5-1 mcg/kg over 10 mins (don’t want brady) Infusion .2-.7 mcg/kg/hr Syringe- 4 mcg/ml (80mcg/20ml)
95
Benzodiazepines-
have many routes- versed (shortest acting) PO IV IM Rectal, intranasally, (50% first pass hepatic ( reversal of benzos- FLUMANZENIL (romazicon) .2 mg iv over 15 seconds redoes 45 seconds if no response… every 1 min can give 4 doses max- does not last as long as the benzo sometimes. ## Footnote Most common- midazolam (versed) children often oral .5mg /kg 30 min before OR.. adult 1-2 mg in preop iv. Its additive. – mild if any vein irritiation Onset of IV meds: 30-60 seconds Duration: 10-20 minutes Induction dose: 0.5-2 mg/kg IV 4-5 mg/kg IM Usual concentrations: 10mg/cc
96
Barbiturate class
Oxybarbituates ( primidine center – O2 atom on #2 carbon)- Methohexital Thiobarbiturates (pyrimidine center) replace the O2 with sulfur on #2 carbon – Thiopental Thiopental- long elimination half-life 12 hours Methohexital ◦ Induction dose ◦ 1-2 mg/kg (IV) ◦ 20-30 mg/kg (Rectal) Thiopental ◦ Induction dose ◦ 2.5-5 mg/kg (IV) ◦ In the elderly reduce the dose by 30-35%
97
Paralytics
CV Succinylcholine – sinus brady, junctional, arrest – more common 2nd dose- children- atropine… action at cardiac muscarinic cholinergic receptors Rocuronium (zemuron)- no effect on BP/ HR Vecuronium (norcruon) – cardiac stable Pancuronium- Vagolytic effects- modest tachycardia – antimuscarinic stimulation- direct sympathomimetic effect- noreepi reduced uptake by adrenergic nerves. Increase HR and CO—sometimes cardiac surgery – high dose opioid counteracted Cisatracurium- no changes CNS SCh - Increased intracranial pressure? Muscular Succinylcholine- Fasciculations- 80-90% if not pretreated with nondepolarizer or NSAID – Myalgias – 50-60%
98
Side effects
SCh- malignant hyperthermia/muscular dystrophy- myoglobinuria … raise K+ .5-1 in healthy people… worse in burns, severe abd infection, metabolic acidosis, upreg extrajunctional ACHR (hemiplegia, paraplegia, muscular dystrophies, guillian-barre syndrome, and burns… Risk in children don’t know if undiagnosed muscle- hyper kalemia , rhabdo. Only emergency increased gastric pressure? Lower esophagial tone? Increased introcular pressure? I Vecuronium (norcuron)- might precipitate with thiopental
99
Histamine paralytics
Mivacurium (Mivacron) – profound histamine release- give slow Atracurium (tracrium)- some release- flush tachycardia hypotension Rocuronium – rare Vecuronium – no histamine Pancuronium (Pavulon)- no histamine Cisatracurium- no release
100
Metabolites paralytics
Vecuronium- not bad one but – 3-desacetyl – 60% potent Pancuronium- need to know 3-OH pancuronium- it is 50% potency and worried about the vagolytic effect get tachycardia Atracurium (tracrium) Laudanosine- rare seizure activity- tertiary amine – CNS stimulant Benzylisoquinolines – hofmann elimination – no organ or enzyme needed temp and ph dependent increase increase metabolism. Mivacurium- hydrolysis by plasma cholinesterase Atracurium metabolism- same enzymes for esmolol and remifentanil – hofmann elminiation 30% and ester hydrolysis for 60% Cisatracurium – 30% hofmann metabolite breakdon by nonspecific esterase
101
Sch
SCh- 1-1.5 mg/kg 20mg/ml succinylcholine
102
Rocuronium
Rocuronium .6 mg/kg RSI 1.2 mg/kg Maintence repeat .1 mg/kg Defasciculating – 5mg or 10mg? Onset 1-2 mins … duration about 30 min RSI 70 min 70% liver 30% renal 10mg/ml?
103
Vecuronium
- Induction .1 mg/kg - 10mg vial- reconstituted with 9ml ns. - Maintain .01 mg/kg - Onset- 2-3 mins 3-5 max - Duration- 25-40 for 25% 45-60 mins 95% - 1mg per ml must dilute first
104
Benylisoquinolines Mivacurium
Benylisoquinolines Mivacurium .2 mg/kg and 5-8 mcg/kg/min onset- 1 min duration 10-20 mins
105
Benylisoquinolines Atracurium, cisatracurium
Atracurium .5 mg/kg onset 2-3mins duration - 20-35 mins – 95% recovery 60-70 mins Cisatracurium .15-.2 – mg/kg onset- 2-3 mins peak 4-7 duration- 40-70 – 20-25 begins and 90% 93 mins 2mg per ml
106
Reversal
Neostigmine- .04-.08 mg/kg – every 1mg/ml od neostigmine mix with .2mg glycol (1ml) Onset- 15 mins – duration 1-2 hrs- hepatic metabolism excretion urine Edrophonium-(more rapid) .5-1mg with 7-10 mcg/kg of atropine enlon .05-.1mg / kg slowly over a min Sugammadex- is different encapsulates modifiec y-cyclodextrin- 8 sugars water soluble binds rocuronium then vecurnoum. T2- 2mg/kg 2 mins, PTC 1-2 – 4mg/kg 3 mins.., 16 mg – given right after dosing 1.5mins recovery- can have negative effects high dose- brady hypo headache arrest itchy – need contraceptieves 7 days \*\* incompatible with verapamil, ondansetron and ranitidine -anaflaxsis- give epinephrine- 10-20 mcg , Benadryl, dexamethasone, and famotidine Physostigmine- only anticholinesterase that crosses BBB- treats anticholinergic toxicity Cholinergic crisis- atropine 35-70 mcg/kg Pralidoxime 15 mcg/kg every 20 mins Benzos Neostigmine and edrophonium are/have: poorly lipid soluble large volumes of distribution